# Combination Chemotherapy and Radiation Therapy Plus Surgery in Treating Patients With Advanced Cancer of the Pancreas

> **NCT00020345** · PHASE2 · COMPLETED · sponsor: **National Institutes of Health Clinical Center (CC)**

## Conditions studied

- Stage IVA Pancreatic Cancer
- Stage III Pancreatic Cancer
- Adenocarcinoma of the Pancreas

## Interventions

- **DRUG:** fluorouracil
- **DRUG:** gemcitabine

## Key facts

- **NCT ID:** NCT00020345
- **Lead sponsor:** National Institutes of Health Clinical Center (CC)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-09
- **Primary completion:** —
- **Final completion:** 2002-03
- **Target enrollment:** — (—)
- **Last updated:** 2023-10-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00020345

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00020345, "Combination Chemotherapy and Radiation Therapy Plus Surgery in Treating Patients With Advanced Cancer of the Pancreas". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00020345. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
